Scarica l'app Stockscreener
1.20
1.69%
0.02
Dopo l'orario di chiusura:
1.20
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché BNGO Giù?
Forum
Previsione
Frazionamento azionario
Bionano Genomics Inc Borsa (BNGO) Ultime notizie
MolDX proposes Medicare coverage for Bionano genome mapping test By Investing.com - Investing.com Canada
Bionano Laboratories Announces Proposed Local Coverage Determination (LCD) from MolDX for Genome-Wide Detection of Structural Variants in Hematologic Neoplasms - The Manila Times
Bionano Genomics (BNGO) interim CEO adds 4,000 shares in IRA - Stock Titan
Bionano Laboratories Announces New York State Department of - globenewswire.com
Bionano to Participate in the H.C. Wainwright 28th Annual Global Investment Conference - Moomoo
Bionano Genomics (NASDAQ:BNGO) Shares Turns Active on Today’s Market Trigger - Kalkine Media
Bionano Genomics Inc. Warrant (BNGOW) Shareholding Pattern – Promoters, FIIs & DIIs - valueresearchonline.com
Bionano Genomics Inc. Warrant (BNGOW) Peer Comparison – Compare with Others - valueresearchonline.com
Bionano Genomics Inc. Warrant (BNGOW) Financials – Balance Sheet, Profit & Loss, Cash Flow - Value Research
Bionano Genomics Inc. Warrant (BNGOW) Key Financial Ratios – Valuation, Profitability & More - Value Research
Bionano Genomics Inc. (BNGO) Shareholding Pattern – Promoters, FIIs & DIIs - valueresearchonline.com
Bionano Genomics Inc. (BNGO) Peer Comparison – Compare with Others - valueresearchonline.com
Bionano Genomics (NASDAQ: BNGO) interim CEO buys 4,000 shares - Stock Titan
Bionano (BNGO) Q2 2026 Results: EPS Exceeds Its Estimate at the Close; Latest Reaction: Shares Fall 0.84% in Latest TradingLong-Term Guidance - vinanet.vn
Why Fast-paced Mover Bionano Genomics (BNGO) Is a Great Choice for Value Investors - qz.com
Bionano Genomics Number of Employees 2026 | Employee Count & Headcount Data - Revelio Labs
Bionano Genomics (BNGO) Q2 2026 Earnings Call Transcript - AOL.com
Alex Reid Hastie Net Worth (2026) - GuruFocus
Bionano Genomics (BNGO) investor discloses 9.9% position via warrants - Stock Titan
Gossamer Bio: Q2 Earnings Snapshot - AOL.com
Analysts Offer Insights on Healthcare Companies: BioNano Genomics (BNGO), Liquidia Technologies (LQDA) and PolyPid (PYPD) - The Globe and Mail
Maxim Group Maintains Bionano Genomics(BNGO.US) With Buy Rating, Maintains Target Price $4 - Moomoo
Bionano Genomics Inc (BNGO) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Bionano Reports Second Quarter 2026 Results and Provides a Business Update - Moomoo
Bionano Genomics earnings beat by $0.13, revenue topped estimates - Investing.com Nigeria
Bionano Genomics, Inc. 2026 Q2ResultsEarnings Call Presentation (NASDAQ:BNGO) 2026-08-11 - Seeking Alpha
Bionano Genomics Q2 2026 Earnings Call Transcript - MarketBeat
Bionano Genomics Inc (BNGO) (Q2 2026) Earnings Call Highlights: - GuruFocus
Bionano Genomics Inc (BNGO) (Q2 2026) Earnings Call Highlights: Record Flow Cell Sales and ... - Yahoo! Finance Canada
Bionano Genomics, Inc. Q2 2026 Earnings Call Summary - Yahoo Finance
Bionano Genomics Q2 Results: Revenue rises 21% to $8.2 million - scanx.trade
Bionano Genomics Q3 Results: Sales guidance ranges $8.200M-$8.600M - scanx.trade
BNGO Looks 21.6% Undervalued on GF Value™ Despite Unprofitabilit - GuruFocus
BIONANO GENOMICS ($BNGO) Releases Q2 2026 Earnings - Quiver Quantitative
How Could Bionano Genomics (NASDAQ:BNGO) Influence Penny Stocks Sentiment? - Kalkine Media
Bionano Genomics, Inc. reports results for the quarter ended June 30Earnings Summary - TradingView
BNGO: Record Q2 revenue and margin driven by clinical adoption, with growth limited by supply constraints - TradingView
Is Bionano Genomics Inc (BNGO) Undervalued After Q2 Earnings? EPS: -$7.4M, Revenue: $8.2M, GF Score: 64/100 - GuruFocus
Transcript : Bionano Genomics, Inc., Q2 2026 Earnings Call, Aug 10, 2026 - marketscreener.com
Earnings call transcript: Bionano Genomics tops Q2 revenue view, shares edge up - Investing.com
Bionano Genomics raises FY26 sales guidance range - scanx.trade
Q2 2026 Bionano Genomics Inc Earnings Call Transcript - GuruFocus
Bionano Genomics Q2 revenue rises on increased clinical adoption - TradingView
BNGO: Q2 2026 revenue rose 21% but liquidity concerns threaten ongoing operations - TradingView
Bionano Reports Q2 2026 Revenue of $8.2M, Gross Margin 53% - TradingView
Bionano Genomics, Inc. Q2 2026: Revenue $8.17M, EPS $(0.64) — 10-Q Summary - TradingView
Bionano Genomics (NASDAQ: BNGO) grows revenue amid going concern warning - Stock Titan
BRIEF-Bionano Genomics Q2 Revenue USD 8.2 Million - TradingView
Bionano Genomics, Inc. Provides Revenue Guidance for the Third Quarter and Full Year of 2026 - marketscreener.com
Bionano Genomics (NASDAQ:BNGO): What Could Today’s Update Reveal About Adoption And Liquidity Ahead Of The Update? - Kalkine Media
BNGO: Q2 2026 revenue rose 21% to $8.2M, with margin gains and raised full-year guidance - TradingView
Bionano Genomics | 8-K: Current report - Moomoo
BNGO Looks 22.1% Undervalued on GF Value™ - GuruFocus
Bionano Genomics, Inc. expected to post a loss of 68 cents a shareEarnings Preview - TradingView
Bionano Genomics Inc (BNGO) Stock News Today - TradingKey
BioNano Genomics Inc (0A4K) Q3 2024 Earnings ReportResults, Call & Slides - TipRanks
BioNano Genomics Inc (0A4K) Q4 2025 Earnings ReportResults, Call & Slides - TipRanks
BioNano Genomics Inc (0A4K) Q4 2024 Earnings ReportResults, Call & Slides - TipRanks
BioNano Genomics Inc (0A4K) Q1 2025 Earnings ReportResults, Call & Slides - TipRanks
BioNano Genomics Inc (0A4K) Q1 2026 Earnings ReportResults, Call & Slides - TipRanks
BioNano Genomics Inc (0A4K) Q3 2025 Earnings ReportResults, Call & Slides - TipRanks
Earnings To Watch: Bionano Genomics Inc (BNGO) Q2 2026 -- GF Val - GuruFocus
Earnings To Watch: Bionano Genomics Inc (BNGO) Q2 2026 -- GF Value Sees 27% Upside - Yahoo Finance
BNGO Q2'26 Earnings: EPS estimate is (0.67) USD - TradingView
BNGO Q1 2026 Earnings: Narrower-Than-Expected Loss Drives 2.8% BumpRevenue Growth Outlook - vinanet.vn
Organogenesis: Q2 Earnings Snapshot - AOL.com
Bionano Genomics (BNGO) grants 5,000 options to officer - Stock Titan
Bionano Genomics (NASDAQ: BNGO) awards 15,000 options to its general counsel - Stock Titan
14.67%
2.17%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):